FT : Italy demands more time from ECB to rescue Monte dei Paschi

Italy demands more time from ECB to rescue Monte dei Paschi
Bank’s board wants until mid-January to pull off €5bn equity injection


Italy is demanding the European Central Bank give it more time to rescue Monte dei Paschi di Siena and is preparing to blame the bank for losses imposed on bondholders if Rome is forced into an urgent state bailout.

The board of MPS, which has the Italian Treasury as its largest shareholder, is asking the ECB’s supervisory arm to give it until mid-January to pull off a €5bn equity injection and try to avoid forcing losses on some debtholders as required under new EU bailout rules, say four people close to the process.

In a letter to the ECB, MPS says political instability unleashed by the resignation of prime minister Matteo Renzi following his defeat in Sunday’s referendum has made it impossible to get the deal done until a new government is formed, these people say.


If the ECB fails to approve the extension, MPS could be heading for a recapitalisation by the Italian state in the next few days, said a person close to the issue. At stake is the stability of the Italian banking system and the potential wider repercussions on Europe’s financial system, which continues to struggle to recover from the eurozone debt crisis of 2010.

A so-called precautionary recapitalisation would involve imposing losses on subordinated debtholders and the indemnification of retail bondholders, the people said. The ECB is due to review the request as early as Thursday.

The ECB is understood to be unwilling to reveal its position until a letter is received. But bankers argue the supervisor is under pressure to take a tougher stance on MPS, which failed the European banks’ healthcheck in 2014 and 2016, potentially paving the way for the latest stand-off between Italy and EU authorities.

“If they don’t give the extension, the ECB must take responsibility. They will be pushing the button,” said one person. “We are only asking for five more weeks.”

Italy has been emboldened to ask for an extension for MPS — which emerged as the weakest lender under European bank stress tests in 2014 and 2016 — after investors shrugged off Mr Renzi’s defeat, reducing the sense of urgency, say senior bankers.
Officials in Brussels have signalled they are willing to support Rome, suggesting that relatively calm markets after the vote have given Italy two months to come up with a solution for MPS with a new government in place. Nonetheless, they say they expect the Siena-based bank will ultimately require a state “bail-in” of some debt holders.

MPS had placed its hopes on a deal with Qatar’s sovereign wealth fund, which would have involved injecting up to €2bn of equity into MPS as a way of securing influence with Mr Renzi over the purchase of more desirable assets, insiders say. The departure of Mr Renzi — who refused a deal struck with Brussels in July to recapitalise the bank and bail-in bondholders, fearing it would lose him votes at the referendum — has thrown the Qatari deal into doubt.


According to people close to the talks, other potential investors, such as US hedge funds, are asking for the new government — preferably led by finance minister Pier Carlo Padoan — to be in place before proceeding. They also want clarity on when national elections may take place. Potential investors would prefer a technocratic government to remain until the end of the legislature in spring 2018, said one person.

MPS and Italy’s Treasury are relying on anchor investors, with senior bankers admitting there is scant market interest in a lender that has already burnt through €8bn in new equity in the past four years.

>>> US Gapping down

Gapping down
In reaction to disappointing earnings/guidance
:
  • SIGM -20.6%, OXM -8%, SEAC -5.4%, NUS -4.5%, (guidance at investor day) HQY -4.4%, AVAV -2.7%, POWL -1.5%
Other news:
  • RPRX -24.1% (provides highlights of yesterday's Bone, Reproductive and Urologic Drugs Advisory Committee Meeting)
  • OHAI -12.9% (provides update on two of is legacy portfolio companies that will likely have a negative impact on the fair value of those investments )
  • LADR -10.2% (prices underwritten secondary public offering of 10 mln shares of Class A common stock by selling shareholders at $13.60/share)
  • PES -9.7% (upsizes offering by 1.5 mln shares and prices 10.5 mln shares of common stock at $5.75 per share)
  • ESV -7.3% (prices offering of $750 mln of 3.00% Exchangeable Senior Notes due 2024)
  • BBG -3.9% (upsizes offering by 2 mln shares and prices 13.5 mln shares of its common stock for gross proceeds of $99.9 mln)
  • IBN -3.2% (reaction to RBI leaving key interest rates unchanged, expected to cut)
  • BLUE -2.3% (prices offering of 3,289,473 shares of its common stock at a public offering price of $76.00 per share)
  • NDRM -1% ( launches a follow-on offering of ordinary shares)
Analyst comments:
  • NTAP -1.4% (downgraded to Underperform from Neutral at Credit Suisse)
  • UL -0.5% (downgraded to Neutral from Overweight at JP Morgan)

>>> US Gapping up

Gapping up
In reaction to strong earnings/guidance
:
  • PLAY +13.3%, EMKR +13.2%, WDC +4.7%, (raises Q2 outlook; renews patent cross-license agreement with Samsung),HOFT +2.2%, KEQU +2%
  • VRA +1.6%, KFY +1.1%
M&A news: AVH +2.3% (responds to media reports regarding its search for a strategic investor; received conditional and confidential proposals from certain parties)

Select EU financial related names showing strength in sympathy with CS investor day (see below): HSBC +1.9%, RBS+1.7%, PUK +1.5%, BCS +0.8%, LYG +0.7%


Other news:
  • ANTH +13.6% (reports Blisibimod BRIGHT-SC IgA Nephropathy continues to demonstrate 'positive' trends in the week 48 analysis; promotes J. Craig Thompson to CEO replacing Paul Truex who has been appointed to new role as Exec Chairman)
  • ENPH +6.6% (continued strength)
  • VKTX +5.8% (confirms the FDA has granted orphan drug designation to VK0214 for the treatment of X-linked adrenoleukodystrophy)
  • WDC +4.6% (raises Q2 outlook; renews patent cross-license agreement with Samsung)
  • SQ +4.4% (Engadget discusses that Square (SQ) users will now be able to spend via Apple (AAPL) Pay)
  • SPWR +4.3% (announces restructuring program; plans to reduce 2017 annual operating expenses to less than $350 mln; provides guidance)
  • WEN +3.9% (Trian Fund Management increases active stake to 23.45% )
  • CS +2.5% (provides strategic update at its Investor Day; targeting lower costs for co's end-2018 objective)
  • AMD +2.1% (in sympathy with WDC)
  • TXMD +2% (among stocks with favorable commentary on Tuesday's Mad Money)
  • MA +1.2% (increases quarterly dividend to $0.22/share from $0.19 prior qtr and approves $4 bln share repurchase program)
  • STX +1.1% (WDC sympathy)
  • JUNO +1% (announces an update of data from studies of its investigational chimeric antigen receptor T cell product candidates was presented; encouraged by the safety and efficacy results )
Analyst comments:
  • RIO +3.7% (upgraded to Outperform from Neutral at Credit Suisse)
  • VALE +3.1% (upgraded to Neutral from Underperform at Credit Suisse)
  • MU +2.3% (initiated with a Buy at Citigroup)
  • GPK +2.1% (upgraded to Buy from Neutral at BofA/Merrill)
  • MELI +1.7% (upgraded to Buy from Neutral at Goldman)
  • AV +1.5% (upgraded to Outperform at RBC Capital Mkts)
  • TEVA +1.5% (resumed with an Outperform at Oppenheimer)
  • AZO +1.2% (upgraded to Overweight from Neutral at JP Morgan)

>>> Brown-Forman reports EPS in-line, revs in-line; reaffirms FY17 EPS guidance

Brown-Forman reports EPS in-line, revs in-line; reaffirms FY17 EPS guidance but lowers underlying net sales, operating income guidance

  • Reports Q2 (Oct) earnings of $0.50 per share, in-line with the Capital IQ Consensus of $0.50; revenues fell 2.8% year/year to $830 mln vs the $837.25 mln Capital IQ Consensus; underlying net sales +3%; underlying operating income +8%.
    • Underlying net sales in the United States and emerging markets improved quarter over quarter.
  • Co reaffirms EPS guidance for FY17, sees EPS of $1.71-1.81 vs. $1.76 Capital IQ Consensus. Lowers underlying net sales growth to 4% to 5% from +4-6%; lowers underlying operating income growth to 6% to 8% from +7-9%

>>> US Early premarket gappers

Early premarket gappers

Gapping up: ANTH +25.9%, VKTX +14.9%, PLAY +13.2%, WDC +5.4%, ENPH +5.1%, RIO +3.6%, VALE +3.4%, CS +3.1%,CHK +2.2%, WEN +2.2%, HSBC +2.1%, GPK +2.1%, MU +2.1%, PBR +1.9%, RBS +1.9%, POWL +1.8%, LYG +1.6%, TEVA+1.5%, AU +1.4%, PUK +1.3%, BCS +1.3%, AZN +1.2%, KEQU +1.2%, MA +0.7%, AMD +0.7%

Gapping down: SIGM -18.1%, OHAI -12.9%, LADR -11.8%, PES -10.4%, AVAV -9.9%, OXM -9.4%, BBG -6.4%, ESV -5.7%,SEAC -5.4%, HQY -4.4%, NDRM -3.4%, IBN -3.2%, HMY -2.7%, BLUE -2.5%, SHPG -1.5%, SIG -1.1%, GSK -0.8%

(MS) Property 2017 Outlook : potential surprises and top picks

Stocks have been pushed around by political and macro factors more than usual this year but despite a busy political calendar in 2017, our strategy colleagues expect this to normalise. From a bottom up perspective we feel most compelled by Spain, by German residential, and by logistics.

How to play UK property stocks? 
The outlook for London offices is challenged with rising supply and most likely sluggish demand, which we think will lead to rental declines and softer yields. UK retail property values are also at risk owing to stagflationary pressures and rising business rates. But then most stocks screen cheap on NAV, some even look good on earnings. Therefore, in absolute terms downside risks may be limited, but we see no clear catalyst to drive these stocks higher while the deterioration in fundamentals accelerates; in relative terms we see more value elsewhere in the sector. We highlight Segro as our most preferred UK name as it is exposed to the compelling logistics market.

Coping with bond yield anxiety. 
Over the long term property stocks' performance relative to European equities tends to be positively correlated with
bond yields, even if this has been different in recent years. Recent underperformance is consistent with previous periods of sudden bond yield rises. But this tends to be short-lived, and a sustained rise in bond yields with higher inflation expectations usually leads to solid property stock performance. Our multi-cycle analysis suggests this could be the right time to revisit attractive equity stories in this sector. We appreciate that this time could indeed be
different, but then history suggests it rarely is.

Top picks. 
Our key OWs are Deutsche Wohnen, LEG and Vonovia (we think German residential yields will fall further despite higher bond yields), Merlin (the cyclical rental recovery is imminent we think), Segro (logistics is one of the most
attractive asset classes in Europe) and Unibail-Rodamco (largely on valuation). 

Potential surprises. 
On the positive side, we think that if we are proven wrong on Spain it will be by not being sufficiently bullish. We also see potential for upside surprise in cities such as Frankfurt driven by financial services demand. On the negative side, we could envisage a material downturn in Swedish property. 

Where could we be wrong ?
Our fundamental bottom-up approach skews our stock positioning towards eurozone stocks. But then we are alive to the fact that next year's political calendar contains several risk events that could potentially reduce the relative attractiveness of eurozone exposure. To some extent our recommendations offer some hedging as several of our OW rated stocks are German, and we would expect strong demand for real assets in Germany in case of heightened risk around the Eurozone.